This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This DIRC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 202-229 amino acids from the Central region of human DIRC2.
DIRC2
Reactivité: Humain, Rat
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
Alexa Fluor 647
Indications d'application
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
anticorps MGC80843, anticorps zgc:92095, anticorps rcc4, anticorps MGC69320, anticorps RCC4, anticorps disrupted in renal carcinoma 2, anticorps disrupted in renal carcinoma 2 L homeolog, anticorps disrupted in renal carcinoma 2 (human), anticorps DIRC2, anticorps dirc2.L, anticorps dirc2, anticorps Dirc2
Sujet
This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.